Harvard 31st Annual Update in Neurology 2023 (Videos)

Harvard 31st Annual Update in Neurology 2023 (Videos) This program provides a comprehensive, evidence-based review of state-of-the-art practices for outpatient and inpatient neurology. Education covers the latest guidelines, clinical strategies, and recent advances, including the use of genetic tests, optimal use of imaging, new approaches for diagnosis, and expanded options for treatment for a wide array of neurological diseases.

Education is practical and focused on patient outcomes. Led by the foremost authorities in neurology subspecialties, the program provides tools to improve your care of patients with common, complex, and rare neurological conditions. As updates are presented, they are paired with specific practice recommendations to help you optimize patient care and outcomes.

Who Should Attend

• Physicians
• Physician Assistants
• Nurses
• Nurse Practitioners

Learning Objectives

Upon completion of this activity, participants will be able to:

• Apply updated research and guidelines for common neurological conditions in their care of patients.
• Explain the principles of delivering neurological care in resource constrained environments.
• Recognize immune mediated neurological diseases and initiate appropriate therapy.
• Identify the most common causes of cognitive error in the diagnosis and treatment of neurological diseases.
• Define types of seizures and mimickers of seizures.
• Recognize and treat common and uncommon headache disorders and dizziness.
• Summarize how to effectively prevent and manage stroke.
• Develop strategies for diagnosing and treating complicated neurologic problems in the outpatient and inpatient settings.

Program :

Monday, October 9, 2023

DAY ONE

Introduction

• Updates in Alzheimer’s Disease
  Dennis J. Selkoe, MD
• Q&A
• State-of-the Art Approaches to the Diagnosis of Dementia
  Scott M. McGinnis, MD
• Q&A
• State-of-the-Art Approaches in the Treatment of Dementia
  Seth A. Gale, MD
• Q&A
• State-of-the-Art Diagnosis of Demyelinating Disease, MS, NMOSD, and MOGAD
  Tanuja Chitnis, MD
• Q&A
• Coma and Disorders of Consciousness*
  Martin A. Samuels, MD
• Q&A
• Updates in the Diagnosis and Medical Management of Parkinsonism
  Albert Y. Hung, MD, PhD
• Q&A
• Non-Pharmacologic Therapy of Movement Disorders
  Michael T. Hayes, MD
• Q&A
• Advances in Our Understanding of Hyperkinetic Movements
  Edison K. Miyawaki, MD
• Q&A with Course Directors
  Sashank Prasad, MD; Tamara B. Kaplan, MD; Isabel Arrillaga-Romany, MD, PhD

Tuesday, October 10, 2023

DAY TWO

• Concussion and Sports-related Neurological Injuries: Guidance to Improve Patient Outcomes
  Claus Reinsberger, MD
• Q&A
• ‘Visual Disturbances
  Sashank Prasad, MD
• Q&A
• State-of-the-Art Approaches in Stroke Prevention and Treatment Prevention and Treatment
  Mariel G. Kozberg, MD, PhD
• Q&A
• Updates in Genetics of Cerebrovascular Disease
  Patricia L. Musolino, MD, PhD
• Q&A
• Current Approach to Myopathies
  Vijay S. Ganesh, MD, PhD
• Q&A
• Keynote: How Neurologists Think: What My Errors Taught Me*
  Martin A. Samuels, MD
• Q&A
• Neurologic Emergencies: Quick Identification and Steps to Optimize Patient Outcomes
  Bradley J. Molyneaux, MD, PhD
• Q&A
• Brain Tumors in 2023: State-of-the-Art and Emerging Treatment Options
  Tracy T. Batchelor, MD, MPH
• Q&A with Course Directors
  Sashank Prasad, MD; Tamara B. Kaplan, MD; Isabel Arrillaga-Romany, MD, PhD

Wednesday, October 11, 2023

DAY THREE

• Best Practices for Diagnosing and Managing Psychogenic Non-Epileptic Seizures
  Barbara A. Dworetzky, MD
• Q&A
• Challenging Epilepsy Cases in Pregnancy
  Paula Emanuela Voinescu, MD
• Q&A
• Updates in Pharmacological Treatment of Epilepsy
  Jong Woo Lee, MD, PhD
• Q&A
• New Concepts in Non-Pharmacologic Treatment of Epilepsy
  Ellen J. Bubrick, MD
• Q&A
• Studying Functional Networks and Targeting Stimulation Treatment of Neuropsychiatric Diseases
  Michael D. Fox, MD, PhD
• Q&A
• Neurogenetics and Impact on Clinical Practice
  Scott R. Plotkin, MD, PhD
• Q&A
• Below-the-Belt Neurology: Bladder, Bowel & Sexual Dysfunction
  Tamara Kaplan, MD
• Q&A
• Keynote: State-of-the-Art Treatment of ALS
  James D. Berry, MD, MPH
• Q&A with Course Directors
  Sashank Prasad, MD; Tamara B. Kaplan, MD; Isabel Arrillaga-Romany, MD, PhD

Thursday, October 12, 2023

DAY FOUR

• Neurological Complications of Checkpoint Inhibition and Other Immunotherapies in Cancer Patients
  Isabel Arrillaga-Romany, MD, PhD
• Q&A
• Evolving Uses of Imaging in Neurology
  Joshua P. Klein, MD, PhD
• Q&A
• Optimizing Your Approach to Treating Multiple Sclerosis
  Eric C. Klawiter, MD
• Q&A
• Modern Diagnosis and Treatment of Cerebellar Ataxias
  Jeremy D. Schmahmann, MD
• Q&A
• Update on Diagnosing and Treating Eye Movement Disorders
  Robert M. Mallery, MD
• Q&A
• Neurology of Skull Base Lesions
  Bart K. Chwalisz, MD
• Q&A
• Treating Neurological Cancer
  Eudocia Quant Lee, MD, MPH
• Q&A
• Alcohol Associated Neurological Disorders
  Michael E. Charness, MD
• Q&A with Course Directors
  Sashank Prasad, MD; Tamara B. Kaplan, MD; Isabel Arrillaga-Romany, MD, PhD

Friday, October 13, 2023

DAY FIVE

• Neuropathy and Neuromuscular Junction: Cases Offering Clinical Pearls
  Christopher T. Doughty, MD
• Q&A
• Updates in the Neurologic Impact of COVID
  Giovanna S. Manzano, MD
• Q&A
• Contemporary Issues in Women’s Neurology
  Mary Angela O’Neal, MD
• Q&A
• Neuroprognotication, Coma and Recovery
  Michael J. Young, MD
• Q&A
• Unusual and Difficult Cases of Headache-Diagnostic Challenges
  Brian E. McGeeney, MD, MPH, MBA
• Q&A
• Delivering the Best Care for Neck and Back Pain
  Shamik Bhattacharyya, MD
• Q&A
• New Treatment Options for Migraine
  Elizabeth W. Loder, MD, MPH
• Q&A
• Treating Headache with Integrative Therapies
  Carolyn A. Bernstein, MD
• Lessons in Global Neurology
  Farrah J. Mateen, MD, PhD
• Q&A with Course Directors
  Sashank Prasad, MD; Tamara B. Kaplan, MD; Isabel Arrillaga-Romany, MD, PhD